Long-term outcome of liver disease-related fibrinogen aguadilla storage disease in a child

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue 6, 2011, Pages 699-

  Maggiore, Giuseppe ^a   Nastasio, Silvia ^a   Sciveres, Marco ^b  

^a UNIVERSITY OF PISA   (Italy)

^b MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; URSODEOXYCHOLIC ACID;

AGUADILLA HEPATIC FIBRINOGEN STORAGE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; DRUG TOLERABILITY; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HUMAN; INBORN ERROR OF METABOLISM; LETTER; LIVER DISEASE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; STORAGE DISEASE; TREATMENT RESPONSE;

FIBRINOGENS, ABNORMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOBETALIPOPROTEINEMIAS; LIVER DISEASES; MALE; METABOLIC DISEASES; MUTATION;

EID: 82355185830     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318232c477     Document Type: Letter

References (11)

1. Sogo T, Nagasaka H, Komatsu H, et al. Fibrinogen storage disease caused by Aguadilla mutation presenting with hypobeta-lipoproteine-mia and considerable liver disease. J Pediatr Gastroenterol Nutr 2009;49:133-6.
2. Francalanci P, Santorelli FM, Talini I, et al. Severe liver disease in early childhood due to fibrinogen storage and de novo gamma375arg! trp gene mutation. J Pediatr 2006;148:396-8.
3. Brennan SO, Maghzal G, Shneider BL, et al. Novel fibrinogen g375 Arg-Trp mutation (fibrinogen Aguadilla) causes hepatic endoplasmic reticulum storage disease and hypofibrinogenemia. Hepatology 2002; 36:652-8. (Pubitemid 34977175)
4. Rubbia-Brandt L, Neerman-Arbez M, Rougemont AL, et al. Fibrinogen gamma 375 arg! trp mutation (fibrinogen Aguadilla) causes hereditary hypofibrinogenemia, hepatic endoplasmic reticulum storage disease and cirrhosis. Am J Surg Pathol 2006;30:906-11. (Pubitemid 44264984)
5. Callea F, Brisigotti M, Fabbretti G, et al. Hepatic endoplasmic reticulum storage diseases. Liver 1992;12:357-62. (Pubitemid 23032692)
6. Lykavieris P, Ducot B, Lachaux A, et al. Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children. J Pediatr Gastroenterol Nutr 2008;47:623-9.
7. Pittschieler K. Vitamin E and liver damage in MZ heterozygous infants with alpha 1-antitrypsin deficiency. Acta Paediatr 1993;82: 228-32. (Pubitemid 23107535)
8. Miller SD, Greene CM, McLean C, et al. Tauroursodeoxycholic acid inhibits apoptosis induced by Z alpha-1-antitrypsin via inhibition of Bad. Hepatology 2007;46:496-503. (Pubitemid 47344785)
9. Rautou PE, Mansouri A, Lebrec D, et al. Autophagy in liver disease. J Hepatol 2010;53:1123-34.
10. Perlmutter DH. The role of autophagy in alpha-1-antitrypsin deficiency. Autophagy 2006;2:258-63.
11. Karim MR, Fujimura S, Kadowaki M. Vitamin E as a novel enhancer of macroautophagy in rat hepatocytes and H4-II-E cells. Biochem Biophys Res Commun 2010;394:981-7.